Table 1 – Sample’s characteristics and results of physician assessment, control questionnaires and lung function tests
1stvisit n = 62 | 2ndvisit n = 61 | |
|---|---|---|
Gender Female n (%) | 37 (60) | 36 (59) |
Age mean (SD) years | 39.6 (14.5) | 39.8 (14.5) |
Physician assessment n (%) | ||
Asthma severity | ||
Intermittent | 12 (19) | 7 (12) |
Mild persistent | 21 (34) | 16 (28) |
Moderate persistent | 24 (39) | 27 (48) |
Severe persistent | 5 (8) | 7 (12) |
Rhinitis classification | ||
Intermittent | 15 (28) | 16 (34) |
Persistent | 38 (72) | 31 (66) |
Mild | 27 (51) | 26 (58) |
Moderate/severe | 26 (49) | 19 (42) |
Control | ||
Both controlled | 24 (39) | 33 (59) |
Only asthma controlled | 15 (24) | 8 (14) |
Only rhinitis controlled | 8 (13) | 6 (11) |
Both uncontrolled | 15 (24) | 9 (16) |
Treatment decision | ||
Reduce | 3 (5) | 2 (4) |
Maintain | 29 (47) | 42 (75) |
Increase | 30 (48) | 12 (21) |
ACQ5 score median (P25-P75) | 1 (0.2-2.5) | 0.8 (0-2.2) |
<0.5 n (%) | 22 (35) | 26 (42) |
0.5–1.5 n (%) | 14 (23) | 12 (20) |
>1.5 n (%) | 26 (42) | 23 (38) |
VAS* median (P25-P75) | ||
All symptoms | 5 (2-7) | 4 (2-6.5) |
Bronchial/pulmonary symptoms | 4 (2-7) | 3 (2-6) |
Nasal symptoms | 5.7 (3-8) | 3 (2-7) |
Lung function mean (sd)# | ||
FVC | 102 (17.1) | 100 (20.8) |
FEV1 | 92 (19.7) | 90 (23) |
PEF | 89 (25) | 88 (26.7) |
F e NO 50 ª | 30 (23.1) | 24 (21.7) |